Thomas Münzel

Showing 1-13 of 13 articles

Effectiveness of additional X-ray protection devices in reducing scattered radiation in radial intervention: the ESPRESSO randomised trial

Anadol R, Brandt M, Merz N, Knorr M, Ahoopai M, Geyer M, Krompiec D, Wenzel P, Münzel T, Gori T

October 23, 2020 | 10.4244/EIJ-D-19-00945

Bioresorbable vascular scaffolds versus everolimus-eluting metallic stents in patients with ST-segment elevation myocardial infarction: 5-year results of the BVS-EXAMINATION study

Brugaletta S, Gori T, Tousek P, Gomez-Lara J, Pinar E, Ortega-Paz L, Schulz E, Kocka V, Münzel T, Cequier A, Buono A, Serruys P, Sabaté M

March 20, 2020 | 10.4244/EIJ-D-19-00773

Interventions for valvular disease

Incidence and in-hospital safety outcomes of patients undergoing percutaneous mitral valve edge-to-edge repair using MitraClip: five-year German national patient sample including 13,575 implants

von Bardeleben R, Hobohm L, Kreidel F, Ostad MA, Schulz E, Konstantinides S, Lankeit M, Feldman T, Münzel T, Keller K

April 16, 2019 | 10.4244/EIJ-D-18-00961

Characteristics and outcome of patients with complex coronary lesions treated with bioresorbable scaffolds: three-year follow-up in a cohort of consecutive patients

Anadol R, Lorenz L, Weissner M, Ullrich H, Polimeni A, Münzel T, Gori T

October 12, 2018 | 10.4244/EIJ-D-17-00410

Everolimus-eluting bioresorbable scaffolds in patients with coronary artery disease: results from the German-Austrian ABSORB RegIstRy (GABI-R)

Nef H, Wiebe J, Kastner J, Mehilli J, Münzel T, Naber C, Neumann T, Richardt G, Schmermund A, Wöhrle J, Zahn R, Riemer T, Achenbach S, Hamm C

December 20, 2017 | 10.4244/EIJ-D-17-00330

Clinical restenosis and its predictors after implantation of everolimus-eluting bioresorbable vascular scaffolds: results from GABI-R

Mehilli J, Achenbach S, Wöhrle J, Baquet M, Riemer T, Münzel T, Nef H, Naber C, Richardt G, Zahn R, Gori T, Neumann T, Kastner J, Schmermund A, Hamm C, Wöhrle J, Richardt G

December 20, 2017 | 10.4244/EIJ-D-17-00291

Twelve-month outcomes after bioresorbable vascular scaffold implantation in patients with acute coronary syndromes. Data from the European Multicenter GHOST-EU Extended Registry

Schnorbus B, Wiebe J, Capodanno D, Brugaletta S, Geraci S, Mehilli J, Latib A, Lesiak M, Jensen C, Mattesini A, Münzel T, Capranzano P, Di Mario C, Naber C, Araszkiewicz A, Colombo A, Caramanno G, Sabaté M, Tamburino C, Nef H, Gori T

October 11, 2017 | 10.4244/EIJ-D-16-00568

Coronary interventions

Predilation, sizing and post-dilation scoring in patients undergoing everolimus-eluting bioresorbable scaffold implantation for prediction of cardiac adverse events: development and internal validation of the PSP score

Ortega-Paz L, Capodanno D, Gori T, Nef H, Latib A, Caramanno G, Di Mario C, Naber C, Lesiak M, Capranzano P, Wiebe J, Mehilli J, Araszkiewicz A, Pyxaras S, Mattesini A, Geraci S, Naganuma T, Colombo A, Münzel T, Sabaté M, Tamburino C, Brugaletta S

April 20, 2017 | 10.4244/EIJ-D-16-00974

Coronary interventions

Early and midterm outcomes of bioresorbable vascular scaffolds for ostial coronary lesions: insights from the GHOST-EU registry

Gori T, Wiebe J, Capodanno D, Latib A, Lesiak M, Pyxaras S, Mehilli J, Caramanno G, Di Mario C, Brugaletta S, Weber J, Capranzano P, Sabaté M, Mattesini A, Geraci S, Naber C, Araszkiewicz A, Colombo A, Tamburino C, Nef H, Münzel T

August 5, 2016 | 10.4244/EIJY15M09_10

Percutaneous coronary intervention with everolimus-eluting bioresorbable vascular scaffolds in routine clinical practice: early and midterm outcomes from the European multicentre GHOST-EU registry

Capodanno D, Gori T, Nef H, Latib A, Mehilli J, Lesiak M, Caramanno G, Naber C, Di Mario C, Colombo A, Capranzano P, Wiebe J, Araszkiewicz A, Geraci S, Pyxaras S, Mattesini A, Naganuma T, Münzel T, Tamburino C

February 20, 2015 | 10.4244/EIJY14M07_11

Early outcome after implantation of Absorb bioresorbable drug-eluting scaffolds in patients with acute coronary syndromes

Gori T, Schulz E, Hink U, Wenzel P, Post F, Jabs A, Münzel T

January 20, 2014 | 10.4244/EIJV9I9A176

The impact of gender on fractional flow reserve measurements

Fineschi M, Guerrieri G, Orphal D, Palmerini E, Münzel T, Warnholtz A, Pierli C, Gori T

July 26, 2013 | 10.4244/EIJV9I3A58

How should I treat a patient with typical angina, typical angiography, negative FFR?

Jabs A, Hink U, Fineschi M, Münzel T, Gori T

May 21, 2013 | 10.4244/EIJV9I1A22

Latest news

EDITORIAL

A State-of-the Art and Mini Focus on Intracoronary OCT; Thrombectomy for Acute Ischaemic Stroke; and more…

June 11, 2021

NEW

Intracoronary OCT: State of the Art and Future Directions

Ziad A. Ali et al.

June 11, 2021

PCR Companion attending EuroPCR? Activate your free subscription!

May 28, 2021

TRIALS BOOK

Access the full Trials Book 2021

(Thanks to the support of Biotronik)

May 18, 2021

JAA

This Week's JAA's: ABSORB DAPT, OFR in predicting post-PCI FFR and more...

June 8, 2021

NEW

Joint EAPCI/ACVC expert consensus on pVADs

Alaide Chieffo et al.

May 31, 2021

JAA

New JAA's: Impact of HPR on clopidogrel monotherapy and more...